BCRX
BioCryst Pharmaceuticals Inc
8.20$
+0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 6.5 | – | – | |
| 14.8 | 17.6 | 20.4 | 15.4 | 14.4 | 19.1 | 24.0 | 19.3 | 36.7 | 43.1 | 39.5 | 36.4 | 27.0 | 9.4 | 6.5 | 15.8 | 11.2 | 74.4 | 56.4 | 35.6 | 22.6 | 16.1 | 16.0 | 9.7 | 9.8 | 7.9 | 5.4 | 4.3 | 4.2 | 3.6 | 3.0 | 3.3 | 3.8 | 3.5 | 3.2 | 3.5 | 2.8 | 2.0 | 2.6 | 2.8 | |
| 81.2 | 294.5 | 16.4 | 18.7 | 4.3 | 5.8 | 7.6 | 12.2 | 11.0 | 18.1 | 39.6 | – | – | 12.0 | 84.5 | 10.1 | 17.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 15.6 | 18.8 | 19.7 | 15.9 | 12.3 | 19.3 | 24.3 | 20.1 | 37.0 | 44.6 | 41.5 | 40.6 | 31.4 | 8.7 | 6.0 | 13.9 | 10.8 | 67.6 | 54.2 | 34.9 | 22.3 | 16.6 | 14.7 | 9.0 | 9.8 | 9.5 | 5.7 | 4.8 | 6.4 | 5.8 | 5.0 | 5.3 | 5.6 | 5.1 | 4.6 | 4.6 | 3.8 | 2.3 | 3.4 | 3.5 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 178.2 | 48.9 | 40.7 | 26.9 | 5.8 | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 125.6 | 34.9 | 5.2 | 7.8 | 7.4 | |
| -22.1% | -11.5% | -6.3% | -8.1% | -7.2% | -8.6% | -11.1% | -10.1% | -9.9% | -10.4% | -11.2% | -26.4% | -32.3% | -19.6% | -28.0% | -12.0% | -17.2% | -10.4% | -9.7% | -6.1% | -6.0% | -5.7% | -5.4% | -8.3% | -7.3% | -7.6% | -8.5% | -9.4% | -8.3% | -8.1% | -9.9% | -6.7% | -3.6% | -3.4% | -1.7% | 0.8% | 2.9% | 19.2% | 12.8% | 13.5% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 98.7% | 89.8% | 90.6% | 90.1% | 86.7% | 93.2% | 92.2% | 93.9% | 97.6% | 97.7% | 91.9% | 86.1% | 86.5% | 91.6% | 94.4% | 94.6% | 92.2% | 90.6% | 76.5% | 90.1% | 93.9% | 95.4% | 99.1% | 99.3% | 98.1% | 97.6% | 97.5% | 97.4% | 98.3% | 98.6% | 98.6% | 98.5% | 98.1% | 97.3% | 96.9% | 97.0% | 97.3% | 97.7% | 18.9% | 23.5% | |
| -262.2% | -184.4% | -129.9% | -149.0% | -157.7% | -227.9% | -349.5% | -246.1% | -398.0% | -456.2% | -449.1% | -1,024.5% | -1,052.5% | -203.7% | -232.6% | -233.1% | -228.8% | -981.1% | -577.7% | -222.7% | -156.1% | -113.1% | -93.8% | -89.1% | -64.7% | -54.8% | -43.8% | -36.8% | -33.8% | -31.3% | -25.3% | -15.8% | -9.9% | -0.6% | 6.6% | 9.7% | 12.7% | 39.0% | -43.1% | -33.3% | |
| -313.0% | -209.3% | -150.2% | -161.0% | -167.6% | -261.2% | -392.1% | -270.9% | -428.0% | -490.3% | -472.1% | -1,091.4% | -1,129.4% | -223.0% | -241.7% | -236.7% | -233.4% | -1,026.4% | -653.7% | -270.5% | -198.9% | -117.1% | -103.2% | -103.0% | -81.1% | -91.2% | -78.1% | -79.2% | -74.4% | -68.4% | -58.7% | -38.2% | -30.0% | -19.7% | -10.6% | -6.4% | -1.5% | 30.2% | -51.7% | -40.9% | |
| -326.5% | -202.8% | -128.7% | -124.8% | -103.7% | -164.7% | -266.8% | -195.8% | -364.3% | -450.0% | -444.7% | -962.3% | -874.1% | -184.1% | -180.5% | -188.6% | -193.3% | -773.2% | -547.4% | -215.5% | -136.6% | -92.0% | -86.0% | -80.3% | -72.3% | -60.3% | -45.8% | -40.4% | -35.3% | -29.4% | -29.1% | -22.4% | -13.7% | -11.8% | -5.3% | 2.8% | 8.0% | 37.6% | 33.2% | 38.0% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -1,722.4% | -3,494.6% | -120.8% | -195.8% | -50.4% | -78.5% | -124.6% | -170.8% | -128.1% | -205.7% | -473.3% | – | – | -284.7% | -3,164.5% | -152.2% | -371.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -75.2% | -61.4% | -35.9% | -41.5% | -26.5% | -36.9% | -49.8% | -57.7% | -55.5% | -69.0% | -74.8% | -108.1% | -147.7% | -62.1% | -84.5% | -54.2% | -70.9% | -54.6% | -73.7% | -77.2% | -85.3% | -31.3% | -36.8% | -41.1% | -34.6% | -44.9% | -44.4% | -45.8% | -45.2% | -43.8% | -44.6% | -30.9% | -25.2% | -18.1% | -11.1% | -7.8% | -2.0% | 51.3% | -98.5% | -69.0% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| 18 | 32 | -21 | 14 | -63 | 4.4 | 6.7 | 22 | 6.4 | 32 | 44 | 48 | 51 | -33 | -20 | -92 | -20 | -121 | -73 | -53 | -36 | 83 | -253 | -126 | -21 | 431 | 80 | 149 | 685 | 703 | 731 | 733 | 734 | 726 | 714 | 605 | 589 | 339 | 673 | 626 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 56.7 | 15.0 | 9.5 | 7.0 | 1.0 | – | – | |
| 4.4% | 1.8% | 29.7% | 21.2% | 52.6% | 47.0% | 39.9% | 33.8% | 43.3% | 33.5% | 15.8% | -7.9% | -45.6% | 21.8% | 2.7% | 35.6% | 19.1% | -5.8% | -26.4% | -38.3% | -55.3% | -18.2% | -31.1% | -41.8% | -43.4% | -53.6% | -295.8% | -298.8% | -78.6% | -88.1% | -101.8% | -100.7% | -95.4% | -97.0% | -94.1% | -92.2% | -86.9% | -23.2% | -119.1% | -81.4% | |
| 13.4 | 34.0 | 1.4 | 2.2 | 0.5 | 0.7 | 0.8 | 1.1 | 0.8 | 1.2 | 3.5 | – | – | 2.1 | 22.3 | 1.1 | 2.3 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -0.93 | -0.75 | -0.62 | -0.59 | -0.61 | -0.67 | -0.78 | -0.80 | -0.89 | -0.92 | -0.97 | -1.14 | -1.21 | -0.83 | -0.75 | -0.72 | -0.71 | -1.04 | -1.18 | -1.20 | -1.27 | -1.01 | -1.05 | -1.13 | -1.04 | -1.32 | -1.20 | -1.28 | -1.25 | -1.12 | -1.01 | -0.71 | -0.60 | -0.43 | -0.25 | -0.16 | -0.04 | 1.20 | -1.89 | -1.45 | |
| 0.30 | 0.36 | 0.41 | 0.36 | 0.36 | 0.26 | 0.20 | 0.29 | 0.21 | 0.19 | 0.20 | 0.10 | 0.11 | 0.37 | 0.31 | 0.30 | 0.30 | 0.10 | 0.18 | 0.44 | 0.64 | 0.86 | 1.02 | 1.10 | 1.28 | 1.45 | 1.54 | 1.62 | 1.67 | 1.65 | 1.72 | 1.85 | 1.99 | 2.17 | 2.34 | 2.54 | 2.73 | 3.99 | 3.66 | 3.55 | |
| 0.05 | 0.02 | 0.51 | 0.30 | 1.20 | 0.85 | 0.63 | 0.47 | 0.69 | 0.45 | 0.20 | -0.08 | -0.37 | 0.29 | 0.02 | 0.47 | 0.19 | -0.11 | -0.42 | -0.60 | -0.82 | -0.59 | -0.89 | -1.15 | -1.30 | -1.58 | -8.00 | -8.37 | -2.17 | -2.26 | -2.31 | -2.30 | -2.26 | -2.29 | -2.10 | -1.92 | -1.76 | -0.54 | -2.29 | -1.71 | |
| -0.97 | -0.72 | -0.53 | -0.45 | -0.38 | -0.42 | -0.53 | -0.58 | -0.75 | -0.85 | -0.91 | -1.00 | -0.94 | -0.68 | -0.56 | -0.57 | -0.59 | -0.78 | -0.99 | -0.96 | -0.87 | -0.79 | -0.87 | -0.88 | -0.93 | -0.87 | -0.70 | -0.66 | -0.59 | -0.48 | -0.50 | -0.42 | -0.27 | -0.26 | -0.12 | 0.07 | 0.22 | 1.50 | 1.21 | 1.35 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.